Washington, D.C., December 4, 2018  – The FDA has recently approved an investigational new drug clinical trial that will start shortly at MedStar Heart & Vascular Institute. The trial, called STEMVAD, is sponsored by MedStar Heart, in partnership with CardioCell, to determine whether stem cell therapy improves myocardial function in patients with severe heart failure—severe enough to require the implantation of a left ventricular assist device, or LVAD. The trial will use CardioCell’s proprietary mesenchymal stem cells (MSCs), and will pioneer the use of a novel delivery strategy, deriving from a new understanding of the causes of progressive heart failure…

Read More

Patients Undergoing Transcatheter Aortic Valve Replacement Showed No Deaths or Disabling Strokes within 30 days of Undergoing Less Invasive Procedure

Read More

Washington, D.C., August 14, 2018 – MedStar Washington Hospital Center is the first hospital in Washington, D.C., to use the Brainlab Airo® Mobile Intraoperative CT, an advanced imaging scanner that gives surgeons a real-time look at the brain or spine during surgery in order to make immediate decisions when it counts the most. Thirty patients have been treated so far at the Hospital Center using the system’s synchronized imaging capabilities. The portable scanner produces high-quality CT images of the patient’s brain or spine in the operating room, allowing surgeons to clearly see their exact position and make the most precise…

Read More